Implication of znf217 in accelerating tumor development and therapeutically targeting ZNF217-induced PI3K–AKT signaling for the treatment of metastatic osteosarcoma

Branden A. Smeester, Garrett M. Draper, Nicholas J. Slipek, Alex T. Larsson, Natalie Stratton, Emily J. Pomeroy, Kelsie L. Becklin, Kenta Yamamoto, Kyle B. Williams, Kanut Laoharawee, Joseph J. Peterson, Juan E. Abrahante, Susan K. Rathe, Lauren J. Mills, Margaret R. Crosby, Wendy A. Hudson, Eric P. Rahrmann, David A. Largaespada, Branden S. Moriarity

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Implication of znf217 in accelerating tumor development and therapeutically targeting ZNF217-induced PI3K–AKT signaling for the treatment of metastatic osteosarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences